Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The pulmonary immune response of Balb/c mice vaccinated with the fusion protein of respiratory syncytial virus.

Vaccine - 1 Jan 1994

Hancock G E, Hahn D J, Speelman D J, Hildreth S W, Pillai S, McQueen K

Abstract excerpt

We have investigated the efficacy of vaccination with the purified fusion (F) protein of respiratory syncytial virus (RSV) on aluminium hydroxide adjuvant in Balb/c mice. The purpose of the study was to define the role of the local pulmonary mononuclear cell (PMC) infiltrate in the clearance of virus from the lower respiratory tract. Balb/c mice immunized with F protein were able to inhibit the replication of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cells, Cultured
Share to Cytotoxicity, Immunologic
Share to Lung

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mice, Inbred BALB C

Share to Phenotype

Share to Recombinant Fusion Proteins

Share to T-Lymphocytes, Cytotoxic

Source

Identifiers

PMID: 8165859
DOI: 10.1016/0264-410x(94)90204-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

The pulmonary immune response of Balb/c mice vaccinated with the fusion protein of respiratory syncytial virus.PMID 8165859Read ↗

Adjuvants recognized by toll-like receptors inhibit the induction of polarized type 2 T cell responses by natural attachment (G) protein of respiratory syncytial virus.Semantic proximity Read ↗

Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells.Semantic proximity Read ↗

Protective antigenic sites identified in respiratory syncytial virus fusion protein reveals importance of p27 domainSemantic proximity Read ↗

Phenotypic and functional characterization of T cell lines specific for individual respiratory syncytial virus proteins.Semantic proximity Read ↗

Immunological properties of plaque purified strains of live attenuated respiratory syncytial virus (RSV) for human vaccine.Semantic proximity Read ↗

Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins.Semantic proximity Read ↗

Onset of immunity with Mycoplasma synoviae: comparison of the live attenuated vaccine MS-H (Vaxsafe MS) with its wild-type parent strain (86079/7NS).Semantic proximity Read ↗

A nontoxic adjuvant for mucosal immunity to pneumococcal surface protein A.Semantic proximity Read ↗

Characterization of T cell clones derived from lymph nodes and lungs of Pseudomonas aeruginosa-susceptible and resistant mice following immunization with heat-killed bacteria.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.